Odilorhabdins Bind to Ribosomes and Disrupt Protein Synthesis in Bacteria
Exciting new discovery describes the mechanism of action of a new class of antibiotics
Exciting new discovery describes the mechanism of action of a new class of antibiotics
A novel technique developed by Stanford scientists will transform cancer research from years of painstaking work to a task accomplished in months
Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers
Presentations on novel developments in CRISPR screening technologies and applications for the DriverMap™ targeted RNA expression profiling assay
New 2D tube with external thread from Micronic provides a simpler way to build your genomic libraries
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
University of Sheffield scientists discover nine novel genes for osteoarthritis
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
New blood test identifies 12 metabolic sub-types of autism spectrum disorder
New blood test provides a unique new framework for early detection of the most common cancers
Josh Haimes, technical lead at ArcherDX, explains how successful NGS is influenced by step-by-step quality control
Flagship exhibition will be held at the Dubai International Convention & Exhibition Centre, Dubai, UAE in February 2018
Scientists across the world share their thoughts on the benefits of being a SelectScience member
A new cost-effective, cloud-based middleware solution helps low-volume laboratories streamline processes and minimize costs
Dr. Megan Allyse from the Mayo Clinic Center for Individualized Medicine explains why gene editing is not yet suitable for medical practice
Detecting and minimizing pre-analytical variables in clinical analysis
New reference standard allows laboratories to optimize, validate and routinely monitor performance of PCR-based tests, NGS, and other novel assays
Dr. Bruce Conklin, UCSF, discusses the potential of genome engineering as a therapy for genetic diseases